InsiderTrades.com logo

CALC Insider Trading

Insider Ownership Percentage: 41.55%
Insider Buying (Last 12 Months): $1,229,000.89
Insider Selling (Last 12 Months): $0.00

CalciMedica Insider Trading History Chart

This chart shows the insider buying and selling history at CalciMedica by year and by quarter.

Skip ChartChart Data in Insider Trading History Table
2022202320242025$0bought$0soldQ2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1Q2-$2M$0$2MTotal Insider BuyingTotal Insider Selling

CalciMedica Share Price & Price History

Current Price: $1.54
Price Change: ▲ Price Increase of +0.025 (1.66%)
As of 04/29/2025 12:44 PM ET

This chart shows the closing price history over time for CALC up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
JunJulAugSepOctNovDecJanFebMarApr$1.51Closing price on 04/28/25:

SEC Filings (Institutional Ownership Changes) for CalciMedica (NASDAQ:CALC)

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at CALC by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table
2022202320242025$61kbought$0soldQ2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1Q2-$2M-$1M$0$1M$2MTotal InflowsTotal Outflows
CalciMedica logo
CalciMedica, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for illnesses caused by inflammatory and immunologic processes and direct cellular damage. The company's lead product candidate comprises Auxora, an intravenous formulated small molecule calcium release-activated (CRAC) channel inhibitors, which is in phase 2 clinical trials for the treatment of acute pancreatitis, asparaginase induced pancreatic toxicity, and acute kidney injury, as well as severe COVID-19 pneumonia. It also develops CM6336, an oral CRAC channel inhibitors for chronic inflammatory indications; and Auxora, for the treatment of acute ulcerative colitis and allergic asthma. The company is based in La Jolla, California.
Read More on CalciMedica

Today's Range

Now: $1.54
Low: $1.52
High: $1.55

50 Day Range

MA: $1.91
Low: $1.48
High: $2.44

52 Week Range

Now: $1.54
Low: $1.43
High: $6.27

Volume

1,152 shs

Average Volume

44,120 shs

Market Capitalization

$20.69 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.22

Who are the company insiders with the largest holdings of CalciMedica?

CalciMedica's top insider investors include:
  1. Fred A Middleton (Director)
  2. Sanderling Venture Partners Vi (Major Shareholder)
  3. Robert N Wilson (Director)
  4. Eric W Roberts (Insider)
  5. A Rachel Leheny (CEO)
Learn More about top insider investors at CalciMedica.

Who are the major institutional investors of CalciMedica?

CalciMedica's top institutional investors include:
  1. Cambridge Investment Research Advisors Inc. — 0.17%
  2. 180 Wealth Advisors LLC — 0.12%
Learn More about top institutional investors of CalciMedica stock.

Which institutional investors are buying CalciMedica stock?

In the last quarter, CALC stock was purchased by institutional investors including:
  1. Cambridge Investment Research Advisors Inc.
  2. 180 Wealth Advisors LLC
Within the last year, these company insiders have bought CalciMedica stock:
  1. Fred A Middleton (Director)
  2. Sanderling Venture Partners Vi (Major Shareholder)
  3. Robert N Wilson (Director)
  4. Eric W Roberts (Insider)
  5. A Rachel Leheny (CEO)
Learn More investors buying CalciMedica stock.